Skip to main content
HairCited

Terapia laser a bassa intensità Figure

3 figure da ricerca revisionata da esperti

Tutti Acidi grassi Omega-3 Caffeina (uso topico) Cheratina Collagene Dutasteride Ferro Finasteride L-Cisteina Microneedling Minoxidil MSM Olio di rosmarino Selenio Spironolattone Terapia laser a bassa intensità Terapia PRP Vitamina B12 Vitamina D Zinco
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Fig. 2. Active treatment group subject pre and post treatment image examples. Hair counts for subject A were 153 at baseline and 221 post treatment. Hair counts for subject B were 108 at baseline and 209 post treatment.
Figure 1 Photograph

Pre- and post-treatment photographs from the active red light therapy group demonstrate visible increases in hair density, with representative subjects showing hair count improvements from 153 to 221 and 108 to 169 hairs respectively.

The growth of human scalp hair in females using visible red light …

Fig. 1. Sham treatment group subject pre and post treatment image examples. Hair counts for subject A were 151 at baseline and 166 post treatment. Hair counts for subject B were 41 at baseline and 44 post treatment.
Figure 2 Photograph

Pre- and post-treatment photographs from the sham device group show minimal changes in hair density, with representative subjects maintaining stable counts of 151 to 166 and 41 to 44 hairs, serving as controls for the red light intervention.

The growth of human scalp hair in females using visible red light …

Figure 2 Examples of PBM devices for alopecia. (A) HairMax LaserComb (Lexington Int, Boca Raton, FL); (B) HairMax LaserBand 82 (Lexington); (C) RedRestore Max Laser Cap 272 (Capillus, Miami, FL); (D) Revage 670 Laser Hood (Apira Science, Boca Raton, FL).
Figure 5 Photograph

Examples of commercially available photobiomodulation devices for alopecia treatment, including the HairMax LaserComb, LaserBand, and various laser cap models from different manufacturers.

Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and …